Terrillion Scott 4
4 · Cara Therapeutics, Inc. · Filed Mar 4, 2024
Insider Transaction Report
Form 4
Terrillion Scott
SEC'Y; CHIEF COMPLIANCE & G.C.
Transactions
- Sale
Common Stock
2024-02-29$0.89/sh−3,293$2,931→ 91,000 total
Footnotes (1)
- [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on September 7, 2018 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.